All forms of ablation today are thermal. While both radiofrequency and cryo ablation have evolved, they nonetheless carry an inherent risk of indiscriminate damage.
PULSED FIELD ABLATION
This is why Pulsed Field Ablation (PFA) has emerged to be the most promising energy source for cardiac ablation, including pulmonary vein isolation. Combining speed with safety, PFA makes durable lesions in a manner of micro-seconds while sparing non-target tissue.
THE DISCRIMINATING ENERGY SOURCE
The true advantage of PFA is its discriminant mode of action. Unlike thermal ablation which destroys all cells in and around the targeted area, PFA is highly tissue specific.
Various tissue types within the heart, including nerve, blood vessel, collagen and endothelium have different tolerances to PFA. Likewise, other structures adjacent to the heart such as the esophagus and phrenic nerve have different tolerances to PFA dosing. Since the electric field threshold that ablates myocardial cells is much lower than other tissues, PFA ablates myocardium without harming critical adjacent structures.
THE FREEDOM TO ABLATE WITH CONFIDENCE
FARAWAVE is an over-the-wire catheter designed to create transmural and circumferential PFA lesions from a femoral approach. Its distal end offers variable morphology designed to treat each patient’s pulmonary vein anatomy with uncompromising and consistent results.
FARAFLEX is a deflectable catheter allowing flexible, focal placement of PFA therapy, including strategies beyond pulmonary vein isolation.
FARAONE creates a rapid, transmural and circumferential lesion around all the pulmonary veins and posterior wall of the left atrium. The catheter is surgically placed with the intent to electrically isolate these structures in micro-seconds, from an epicardial approach and without the need for cardiopulmonary bypass.
SAFETY, SPEED, EFFICACY
Our team is dedicated to bringing FARAPULSE PFA into EP labs across the globe. Tissue-selective. Rapid. Effective. That’s the future of cardiac ablation.